Skip to main content
Top
Published in: BMC Health Services Research 1/2018

Open Access 01-12-2018 | Research article

State variation in opioid treatment policies and opioid-related hospital readmissions

Authors: Janice Blanchard, Audrey J. Weiss, Marguerite L. Barrett, Kimberly W. McDermott, Kevin C. Heslin

Published in: BMC Health Services Research | Issue 1/2018

Login to get access

Abstract

Background

State policy approaches designed to provide opioid treatment options have received significant attention in addressing the opioid epidemic in the United States. In particular, expanded availability of naloxone to reverse overdose, Good Samaritan laws intended to protect individuals who attempt to provide or obtain emergency services for someone experiencing an opioid overdose, and expanded coverage of medication-assisted treatment (MAT) for individuals with opioid abuse or dependence may help curtail hospital readmissions from opioids. The objective of this retrospective cohort study was to evaluate the association between the presence of state opioid treatment policies—naloxone standing orders, Good Samaritan laws, and Medicaid medication-assisted treatment (MAT) coverage—and opioid-related hospital readmissions.

Methods

We used 2013–2015 hospital inpatient discharge data from 13 states from the Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project. We examined the relationship between state opioid treatment policies and 90-day opioid-related readmissions after a stay involving an opioid diagnosis.

Results

Our sample included 383,334 opioid-related index hospitalizations. Patients treated in states with naloxone standing-order policies at the time of the index stay had higher adjusted odds of an opioid-related readmission than did those treated in states without such policies; however, this relationship was not present in states with Good Samaritan laws. Medicaid methadone coverage was associated with higher odds of readmission among all insurance groups except Medicaid. Medicaid MAT coverage generosity was associated with higher odds of readmission among the Medicaid group but lower odds of readmission among the Medicare and privately insured groups. More comprehensive Medicaid coverage of substance use disorder treatment and a greater number of opioid treatment programs were associated with lower odds of readmission.

Conclusions

Differences in index hospitalization rates suggest that states with opioid treatment policies had a higher level of need for opioid-related intervention, which also may account for higher rates of readmission. More research is needed to understand how these policies can be most effective in influencing acute care use.
Footnotes
1
We did not include data for quarter 4 of 2015 because of the transition during this time from the ICD-9-CM to the ICD-10-CM/PCS coding system, which previous research suggests may have issues with compatibility [50].
 
2
We used hospital discharges in January through March 2013 only for assessment of the 90-day pre-index period and discharges from July through September 2015 only for assessment of the 90-day post-index readmission period.
 
Literature
Metadata
Title
State variation in opioid treatment policies and opioid-related hospital readmissions
Authors
Janice Blanchard
Audrey J. Weiss
Marguerite L. Barrett
Kimberly W. McDermott
Kevin C. Heslin
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2018
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-018-3703-8

Other articles of this Issue 1/2018

BMC Health Services Research 1/2018 Go to the issue